Skip to main content
Clinical Trials/NCT02207647
NCT02207647TerminatedNot Applicable

Prevalence of Pathogens in Cerebrospinal Fluid Obtained From Emergency Department Patients

Olive View-UCLA Education & Research Institute1 site in 1 country1,000 target enrollmentStarted: April 2014Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Sponsor
Enrollment
1,000
Locations
1
Primary Endpoint
prevalence of pathogens

Study Overview

Brief Summary

Of all emergency room patients, persons presenting with encephalitis/meningitis syndrome of a potentially infectious nature are among those of greatest concern. Routine clinical and laboratory evaluation of such patients involves screening for known infectious disease agents, selection of which is nonstandardized. Progress in diagnostic technologies, especially molecular techniques based on genetic characteristics of potential pathogens, has greatly expanded the investigators capacity to evaluate specimens from patients for a much wider range of potential pathogens (bacterial, viral, fungal and parasitic agents). Use of Polymerase Chain Reaction (PCR) technology offers the possibility of identifying causative agents for the approximately 50% of all such presentations which go un-diagnosed. The investigators propose a study involving a collaboration between the EMERGEncy ID NET, a network of 10 geographically diverse university-affiliated urban emergency departments (coordinated by Olive View-UCLA Medical Center) and the Centers for Disease Control and Prevention (CDC), to use these new technologies to address this issue.

Study Design

Study Type
Observational
Observational Model
Ecologic Or Community
Time Perspective
Prospective

Eligibility Criteria

Ages
3 Months to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age > or = 3 months old
  • Receiving a Lumbar Puncture in the emergency department as part of their standard care.

Exclusion Criteria

  • No CSF available

Outcomes

Primary Outcomes

prevalence of pathogens

Time Frame: 2 years

We will describe the range and proportion of pathogens found in CSF among patients enrolled over a 2 year period.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Olive View-UCLA Education & Research Institute
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

David A. Talan

Principal Investigator

Olive View-UCLA Education & Research Institute

Study Sites (1)

Loading locations...

Similar Trials

Prevalence of Pathogens in Cerebrospinal... | Clinical Trial